Published in J Virol on July 21, 2010
SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection. PLoS Pathog (2011) 2.65
G3BP1, G3BP2 and CAPRIN1 are required for translation of interferon stimulated mRNAs and are targeted by a dengue virus non-coding RNA. PLoS Pathog (2014) 1.84
DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog (2012) 1.80
Mouse STAT2 restricts early dengue virus replication. Cell Host Microbe (2010) 1.53
Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination. PLoS Pathog (2012) 1.44
Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog (2012) 1.44
Innate immunity evasion by Dengue virus. Viruses (2012) 1.29
Arterivirus and nairovirus ovarian tumor domain-containing Deubiquitinases target activated RIG-I to control innate immune signaling. J Virol (2011) 1.21
Defining Hsp70 Subnetworks in Dengue Virus Replication Reveals Key Vulnerability in Flavivirus Infection. Cell (2015) 1.20
Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling. PLoS Pathog (2013) 1.20
Innate immunity to dengue virus infection and subversion of antiviral responses. J Mol Biol (2013) 1.17
Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response. J Virol (2014) 1.03
Endothelial cells elicit immune-enhancing responses to dengue virus infection. J Virol (2012) 1.00
Delayed cytosolic exposure of Japanese encephalitis virus double-stranded RNA impedes interferon activation and enhances viral dissemination in porcine cells. J Virol (2011) 0.95
Novel ATP-independent RNA annealing activity of the dengue virus NS3 helicase. PLoS One (2012) 0.95
The cGAS-STING Defense Pathway and Its Counteraction by Viruses. Cell Host Microbe (2016) 0.93
Dengue virus type 3 isolated from a fatal case with visceral complications induces enhanced proinflammatory responses and apoptosis of human dendritic cells. J Virol (2011) 0.91
Decreased dengue replication and an increased anti-viral humoral response with the use of combined Toll-like receptor 3 and 7/8 agonists in macaques. PLoS One (2011) 0.91
Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways. Trends Microbiol (2013) 0.90
Structure and dynamics of the second CARD of human RIG-I provide mechanistic insights into regulation of RIG-I activation. Structure (2012) 0.90
Dengue virus type 2 modulates endothelial barrier function through CD73. Am J Trop Med Hyg (2012) 0.89
Evasion of the human innate immune system by dengue virus. Immunol Res (2012) 0.87
Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection. Cytokine Growth Factor Rev (2014) 0.86
Sensing of immature particles produced by dengue virus infected cells induces an antiviral response by plasmacytoid dendritic cells. PLoS Pathog (2014) 0.86
Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS. J Virol (2016) 0.83
Dengue virus serotype 2 blocks extracellular signal-regulated kinase and nuclear factor-κB activation to downregulate cytokine production. PLoS One (2012) 0.83
The role of endothelial activation in dengue hemorrhagic fever and hantavirus pulmonary syndrome. Virulence (2013) 0.83
2 methylate or not 2 methylate: viral evasion of the type I interferon response. Nat Immunol (2011) 0.83
Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses. Sci Rep (2016) 0.83
Dengue Virus Control of Type I IFN Responses: A History of Manipulation and Control. J Interferon Cytokine Res (2015) 0.83
Dendritic cell apoptosis and the pathogenesis of dengue. Viruses (2012) 0.82
Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IκB kinase epsilon interaction. Clin Vaccine Immunol (2013) 0.81
Influenza A virus-mediated priming enhances cytokine secretion by human dendritic cells infected with Streptococcus pneumoniae. Cell Microbiol (2013) 0.81
STAT2 signaling and dengue virus infection. JAKSTAT (2014) 0.80
Interferon lambda inhibits dengue virus replication in epithelial cells. Virol J (2015) 0.79
Mechanisms of innate immune evasion in re-emerging RNA viruses. Curr Opin Virol (2015) 0.78
Oligomeric procyanidins stimulate innate antiviral immunity in dengue virus infected human PBMCs. Antiviral Res (2011) 0.78
Differential expression of Toll-like receptors in dendritic cells of patients with dengue during early and late acute phases of the disease. PLoS Negl Trop Dis (2013) 0.77
Chikungunya vaccines in development. Hum Vaccin Immunother (2016) 0.76
Activation of Nrf2 by the dengue virus causes an increase in CLEC5A, which enhances TNF-α production by mononuclear phagocytes. Sci Rep (2016) 0.75
Single point mutations in the helicase domain of the NS3 protein enhance dengue virus replicative capacity in human monocyte-derived dendritic cells and circumvent the type I interferon response. Clin Exp Immunol (2015) 0.75
DENV up-regulates the HMG-CoA reductase activity through the impairment of AMPK phosphorylation: A potential antiviral target. PLoS Pathog (2017) 0.75
Dengue virus NS1 enhances viral replication and pro-inflammatory cytokine production in human dendritic cells. Virology (2016) 0.75
Antagonism of type I interferon by flaviviruses. Biochem Biophys Res Commun (2017) 0.75
High-dimensional CyTOF analysis of dengue virus-infected human DCs reveals distinct viral signatures. JCI Insight (2017) 0.75
Pathogen recognition and innate immunity. Cell (2006) 44.14
Immunobiology of dendritic cells. Annu Rev Immunol (2000) 23.65
Dengue and dengue hemorrhagic fever. Clin Microbiol Rev (1998) 19.59
Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology (1998) 9.81
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol (2008) 8.85
Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol (2007) 7.18
Type 1 interferons and the virus-host relationship: a lesson in détente . Science (2006) 6.33
Human skin Langerhans cells are targets of dengue virus infection. Nat Med (2000) 5.74
The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A (2000) 5.46
Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A (2005) 5.31
Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A (2003) 5.05
Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A (2006) 4.84
DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med (2003) 4.69
Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe (2009) 4.54
Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol (2003) 4.45
Molecular biology of flaviviruses. Adv Virus Res (2003) 4.39
Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol (2005) 4.31
Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol (2002) 3.91
Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc Natl Acad Sci U S A (2004) 3.85
Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol (2000) 3.61
Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep (2003) 3.29
Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol (2006) 2.94
Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol (2006) 2.76
Recombinant Newcastle disease virus as a vaccine vector. J Virol (2001) 2.67
Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol (2000) 2.49
NS5 of dengue virus mediates STAT2 binding and degradation. J Virol (2009) 2.42
Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol (2001) 2.39
Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol (2005) 2.37
Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A (2006) 2.23
TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses. J Immunol (2004) 2.10
Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol (2004) 2.01
Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. J Biol Chem (2000) 2.00
Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J Infect Dis (2009) 1.83
Viruses and the type I interferon antiviral system: induction and evasion. Int Rev Immunol (2002) 1.73
Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J Virol (2005) 1.69
Two-helper RNA system for production of recombinant Semliki forest virus particles. J Virol (1999) 1.69
Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J Immunol (2005) 1.63
Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrity. Cell Host Microbe (2010) 1.56
Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol (2010) 1.42
Differential effects of dengue virus on infected and bystander dendritic cells. J Virol (2005) 1.33
Viral suppression of the interferon system. Biochimie (2007) 1.30
Early alpha/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88. J Virol (2005) 1.30
Mechanisms of evasion of the type I interferon antiviral response by flaviviruses. J Interferon Cytokine Res (2009) 1.28
Induction of type I interferon by RNA viruses: cellular receptors and their substrates. Amino Acids (2009) 1.22
The influenza virus NS1 protein: inhibitor of innate and adaptive immunity. Infect Disord Drug Targets (2007) 1.21
Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. Virology (2008) 1.20
Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus. J Leukoc Biol (2008) 1.09
Host cell killing by the West Nile Virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway. Virology (2005) 1.05
Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas. Mol Ther (2005) 0.99
Subversion of interferon by dengue virus. Curr Top Microbiol Immunol (2010) 0.99
Antiviral-activated dendritic cells: a paracrine-induced response state. J Immunol (2008) 0.97
In vitro determination of dengue virus type 2 NS2B-NS3 protease activity with fluorescent peptide substrates. J Biochem Mol Biol (2002) 0.94
Langat flavivirus protease NS3 binds caspase-8 and induces apoptosis. J Virol (2002) 0.92
Viral evasion of the interferon system. J Interferon Cytokine Res (2009) 0.90
Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor. Proteins (2006) 0.83
Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol (2005) 4.31
Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A (2010) 3.17
SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection. PLoS Pathog (2011) 2.65
The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J Virol (2010) 1.94
DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog (2012) 1.80
Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector. J Virol (2006) 1.73
Transcriptional role of p53 in interferon-mediated antiviral immunity. J Exp Med (2008) 1.72
The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. Immunity (2013) 1.69
Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach. J Virol (2008) 1.64
The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog (2011) 1.60
Mouse STAT2 restricts early dengue virus replication. Cell Host Microbe (2010) 1.53
Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol (2010) 1.42
Chromosome-specific and noisy IFNB1 transcription in individual virus-infected human primary dendritic cells. Nucleic Acids Res (2007) 1.40
Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J Virol (2011) 1.35
Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus. PLoS Pathog (2008) 1.32
Innate immunity evasion by Dengue virus. Viruses (2012) 1.29
Safety and efficacy of various combinations of injectable anesthetics in BALB/c mice. J Am Assoc Lab Anim Sci (2008) 1.28
Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses. J Virol (2012) 1.20
Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling. PLoS Pathog (2013) 1.20
Effects of receptor binding specificity of avian influenza virus on the human innate immune response. J Virol (2011) 1.20
H7N9 influenza viruses interact preferentially with α2,3-linked sialic acids and bind weakly to α2,6-linked sialic acids. J Gen Virol (2013) 1.19
The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses. J Virol (2011) 1.16
Serological detection of West Nile virus in horses and chicken from Pantanal, Brazil. Mem Inst Oswaldo Cruz (2012) 1.15
Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins. J Gen Virol (2005) 1.11
Vesicle formation by self-assembly of membrane-bound matrix proteins into a fluidlike budding domain. J Cell Biol (2007) 1.10
A transient homotypic interaction model for the influenza A virus NS1 protein effector domain. PLoS One (2011) 1.07
Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus. Nature (2013) 1.01
Priming of CD8+ T cell responses following immunization with heat-killed Plasmodium sporozoites. Eur J Immunol (2006) 0.98
Type I interferon imposes a TSG101/ISG15 checkpoint at the Golgi for glycoprotein trafficking during influenza virus infection. Cell Host Microbe (2013) 0.98
Estrogen inhibits dendritic cell maturation to RNA viruses. Blood (2008) 0.96
A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon. PLoS Pathog (2012) 0.96
Herpes simplex virus 2 (HSV-2) prevents dendritic cell maturation, induces apoptosis, and triggers release of proinflammatory cytokines: potential links to HSV-HIV synergy. J Virol (2012) 0.95
Humoral and cell-mediated immune responses to monovalent 2009 influenza A/H1N1 and seasonal trivalent influenza vaccines in high-risk children. J Pediatr (2011) 0.94
Innate immunity to H5N1 influenza viruses in humans. Viruses (2012) 0.94
Intact sphingomyelin biosynthetic pathway is essential for intracellular transport of influenza virus glycoproteins. Proc Natl Acad Sci U S A (2013) 0.92
New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions. Antiviral Res (2013) 0.92
Cofactors required for TLR7- and TLR9-dependent innate immune responses. Cell Host Microbe (2012) 0.91
Innate immune sensing of flaviviruses. PLoS Pathog (2013) 0.89
Recombinant influenza A viruses with enhanced levels of PB1 and PA viral protein expression. J Virol (2012) 0.87
Evasion of the human innate immune system by dengue virus. Immunol Res (2012) 0.87
Identification of small molecules with type I interferon inducing properties by high-throughput screening. PLoS One (2012) 0.87
Efficient development of plasmodium liver stage-specific memory CD8+ T cells during the course of blood-stage malarial infection. J Infect Dis (2007) 0.86
Attenuated influenza virus construct with enhanced hemagglutinin protein expression. J Virol (2012) 0.86
Contribution of double-stranded RNA and CPSF30 binding domains of influenza virus NS1 to the inhibition of type I interferon production and activation of human dendritic cells. J Virol (2012) 0.84
Cell receptors for influenza a viruses and the innate immune response. Front Microbiol (2012) 0.84
Substitutions T200A and E227A in the hemagglutinin of pandemic 2009 influenza A virus increase lethality but decrease transmission. J Virol (2013) 0.84
The combined effect of two mutations that alter serially homologous color pattern elements on the fore and hindwings of a butterfly. BMC Genet (2007) 0.84
Distinct molecular mechanisms responsible for bortezomib-induced death of therapy-resistant versus -sensitive B-NHL cells. Blood (2010) 0.83
Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virus. J Biol Chem (2013) 0.83
Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge. Virology (2004) 0.82
HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes. J Virol (2014) 0.82
Hemagglutinin Receptor Binding of a Human Isolate of Influenza A(H10N8) Virus. Emerg Infect Dis (2015) 0.81
Antiviral immunity and the role of dendritic cells. Int Rev Immunol (2002) 0.81
A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin Infect Dis (2008) 0.81
Synergism of CPT-11 and Apo2L/TRAIL against two differentially sensitive human colon tumor xenografts. Oncology (2008) 0.79